Kratom and 7-OH Withdrawal: What to Expect When You Stop

Kratom occupies a strange space in American drug use: sold legally in most states at gas stations and smoke shops, marketed with wellness language, and pharmacologically an opioid-receptor drug. Its main active compounds — mitragynine and 7-hydroxymitragynine — act on the same receptor systems as opioids. So it should surprise nobody that regular heavy use produces dependence, and stopping produces a withdrawal that looks, in most respects, like a milder cousin of opioid withdrawal.

That word "milder" is doing less work every year, and the reason is concentration.

Leaf kratom vs. 7-OH: not the same conversation

Traditional kratom — powdered leaf, brewed or capsuled — delivers mitragynine with small amounts of 7-hydroxymitragynine. The newer generation of products flips that math. Concentrated 7-OH tablets, gummies, and shots deliver purified or synthesized 7-hydroxymitragynine, which is dramatically more potent at the opioid receptor than the leaf it came from. The FDA has warned that these concentrated products are, functionally, unapproved opioids sold over the counter, and has seized them. In July 2026 the DEA proposed placing concentrated 7-OH in Schedule I, and in August 2026 it placed three related compounds (mitragynine pseudoindoxyl, MGM-15, MGM-16) in Schedule I. Check current status before relying on any product being legal.

In practice, users of concentrated 7-OH products report developing tolerance quickly and dosing more often, and the withdrawal they describe is not "herbal" in any meaningful sense — it is opioid withdrawal. If that is your situation, read our opioid withdrawal guide alongside this one, because most of it applies.

What stopping tends to involve

People who stop regular kratom use commonly report, usually beginning within a day or so of the last dose:

• Muscle and joint aches, restlessness, jerky or restless legs at night
• Runny nose, watery eyes, sweating, chills — the classic opioid-withdrawal picture
• Irritability and anxiety, sometimes sharp
• Insomnia, often the longest-running symptom
• Nausea, cramping, diarrhea
• Low mood and fatigue
• Cravings, frequently tied to the routine — the morning scoop, the workday dosing schedule

Severity tracks with the pattern: how much, how often, how concentrated, how long. A person taking a few grams of leaf powder daily and a person taking 7-OH tablets every three hours are having two different experiences, and the second one should plan accordingly. Acute symptoms commonly ease within a week or so; sleep and mood take longer. Formal research on kratom withdrawal is still thin compared to classical opioids — timelines here are drawn from case reports and clinical experience, which is itself a fact worth knowing.

The self-treatment trap

Ask people why they started kratom and the answers cluster fast: chronic pain, anxiety, energy, or — very commonly — getting off something else. Kratom has a reputation as an exit ramp from opioids or alcohol, and some people genuinely used it that way. The trouble is that an opioid-receptor drug taken daily is not an exit from opioid dependence; it is a lateral move that feels like progress, at gas-station prices and with no clinician involved. When the kratom use itself becomes hard to control — dosing around the clock, buying in bulk, withdrawal between doses — the exit ramp has become the highway.

None of this is said to shame anyone. It is said because the fix is the same one that works for every other opioid-receptor drug: honest assessment, medical support for the discontinuation, and treatment for whatever the substance was quietly managing.

How clinicians approach it

There is no medication approved specifically for kratom dependence, and no standard protocol yet — the research base is young. In practice, clinicians treat significant kratom or 7-OH dependence much the way they treat opioid dependence: supportive medications for the acute symptoms, and in heavier cases, some addiction medicine physicians use medications for opioid use disorder, including buprenorphine, based on clinical judgment and published case experience. Whether that fits any individual case is exactly the kind of decision that needs a prescriber in the room.

What you can do to make that appointment productive: bring the actual product, or a photo of it, and the honest math on daily quantity. Kratom rarely shows up on standard drug panels, so the history you volunteer is the history the clinician has.

Next step

If quitting kratom keeps not happening — the taper that resets every Monday, the last bag that wasn't — treat that as information rather than failure. Dependence on an opioid-receptor drug is a medical situation with medical answers. Our treatment options guide explains which levels of support are often considered, our guide to choosing a treatment program covers what to verify before committing to one, and SAMHSA's free, confidential helpline (1-800-662-4357) is available 24/7.